Steven A. Yukl

4.3k total citations
49 papers, 1.8k citations indexed

About

Steven A. Yukl is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Steven A. Yukl has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Virology, 34 papers in Infectious Diseases and 16 papers in Immunology. Recurrent topics in Steven A. Yukl's work include HIV Research and Treatment (41 papers), HIV/AIDS Research and Interventions (23 papers) and HIV/AIDS drug development and treatment (19 papers). Steven A. Yukl is often cited by papers focused on HIV Research and Treatment (41 papers), HIV/AIDS Research and Interventions (23 papers) and HIV/AIDS drug development and treatment (19 papers). Steven A. Yukl collaborates with scholars based in United States, Australia and Switzerland. Steven A. Yukl's co-authors include Joseph K. Wong, Peggy Kim, Sushama Telwatte, Philipp Kaiser, Harry Lampiris, Steven G. Deeks, Diane V. Havlir, Elizabeth Sinclair, Sunil K. Joshi and Peilin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Steven A. Yukl

48 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven A. Yukl United States 24 1.4k 954 579 416 312 49 1.8k
María Salgado Spain 20 844 0.6× 542 0.6× 433 0.7× 238 0.6× 184 0.6× 49 1.1k
Annie David France 17 864 0.6× 482 0.5× 682 1.2× 246 0.6× 233 0.7× 22 1.2k
Fabio Romerio United States 21 844 0.6× 447 0.5× 726 1.3× 603 1.4× 217 0.7× 50 1.6k
Simon Swingler United States 11 1.2k 0.8× 630 0.7× 574 1.0× 425 1.0× 278 0.9× 13 1.5k
Amy E. Baxter United States 17 722 0.5× 462 0.5× 749 1.3× 362 0.9× 222 0.7× 26 1.5k
Stanley Kang United States 8 1.2k 0.9× 599 0.6× 852 1.5× 258 0.6× 193 0.6× 8 1.5k
I S Chen United States 8 1.1k 0.7× 558 0.6× 512 0.9× 325 0.8× 240 0.8× 8 1.3k
María Rosa López‐Huertas Spain 21 655 0.5× 505 0.5× 377 0.7× 331 0.8× 244 0.8× 46 1.2k
David J. Hooker Australia 10 1.1k 0.8× 668 0.7× 435 0.8× 247 0.6× 314 1.0× 14 1.3k
Matthew Pace United Kingdom 17 830 0.6× 503 0.5× 387 0.7× 193 0.5× 188 0.6× 33 1000

Countries citing papers authored by Steven A. Yukl

Since Specialization
Citations

This map shows the geographic impact of Steven A. Yukl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Yukl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Yukl more than expected).

Fields of papers citing papers by Steven A. Yukl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Yukl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Yukl. The network helps show where Steven A. Yukl may publish in the future.

Co-authorship network of co-authors of Steven A. Yukl

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Yukl. A scholar is included among the top collaborators of Steven A. Yukl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Yukl. Steven A. Yukl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Sun Jin, Rebecca Hoh, Satish K. Pillai, et al.. (2025). Longitudinal changes in the transcriptionally active and intact HIV reservoir after starting ART during acute infection. Journal of Virology. 99(3). e0143124–e0143124. 1 indexed citations
2.
Kim, Peggy, Sun Jin Kim, Peter W. Hunt, et al.. (2024). Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivo. JCI Insight. 9(19). 4 indexed citations
3.
Telwatte, Sushama, Sun Jin Kim, Peggy Kim, et al.. (2024). Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules. AIDS. 38(9). 1281–1291. 3 indexed citations
4.
Tumpach, Carolin, Ajantha Rhodes, Youry Kim, et al.. (2023). Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA. Viruses. 15(7). 1606–1606. 10 indexed citations
5.
Telwatte, Sushama, Nitasha Kumar, Sara Morón‐López, et al.. (2022). Novel assays to investigate the mechanisms of latent infection with HIV-2. PLoS ONE. 17(4). e0267402–e0267402. 2 indexed citations
6.
Telwatte, Sushama, Nitasha Kumar, Albert Vallejo-Gracia, et al.. (2021). Novel RT-ddPCR assays for simultaneous quantification of multiple noncoding and coding regions of SARS-CoV-2 RNA. Journal of Virological Methods. 292. 114115–114115. 16 indexed citations
7.
Telwatte, Sushama, Parinaz Fozouni, Albert Vallejo-Gracia, et al.. (2021). Novel RT-ddPCR assays for measuring the levels of subgenomic and genomic SARS-CoV-2 transcripts. Methods. 201. 15–25. 26 indexed citations
8.
Timmons, Andrew E., Emily J. Fray, Mithra R. Kumar, et al.. (2020). HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo. Proceedings of the National Academy of Sciences. 117(27). 15763–15771. 25 indexed citations
9.
Frouard, Julie, Andrea Gramatica, Guorui Xie, et al.. (2020). Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection. PLoS Pathogens. 16(4). e1008450–e1008450. 26 indexed citations
10.
Telwatte, Sushama, Sara Morón‐López, Dvir Aran, et al.. (2019). Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency. Retrovirology. 16(1). 32–32. 38 indexed citations
11.
Telwatte, Sushama, Sulggi A. Lee, Ma Somsouk, et al.. (2018). Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency. PLoS Pathogens. 14(11). e1007357–e1007357. 75 indexed citations
12.
Yukl, Steven A., Philipp Kaiser, Peggy Kim, et al.. (2018). HIV latency in isolated patient CD4 + T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. Science Translational Medicine. 10(430). 225 indexed citations
13.
Trapečar, Martin, Shahzada Khan, Nadia R. Roan, et al.. (2017). An Optimized and Validated Method for Isolation and Characterization of Lymphocytes from HIV+ Human Gut Biopsies. AIDS Research and Human Retroviruses. 33(S1). S–31. 23 indexed citations
14.
Khan, Shahzada, Sushama Telwatte, Martin Trapečar, Steven A. Yukl, & Shomyseh Sanjabi. (2017). Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure. AIDS Research and Human Retroviruses. 33(S1). S–40. 19 indexed citations
15.
Cockerham, Leslie R., Steven A. Yukl, Ma Somsouk, et al.. (2017). A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals. SHILAP Revista de lepidopterología. 2(3). 310–310. 9 indexed citations
16.
Lee, Sulggi A., Peter Bacchetti, Nicolas Chomont, et al.. (2016). Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy. PLoS ONE. 11(8). e0160192–e0160192. 23 indexed citations
17.
Li, Peilin, Philipp Kaiser, Harry Lampiris, et al.. (2016). Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Nature Medicine. 22(7). 807–811. 88 indexed citations
18.
Li, Peilin, et al.. (2014). Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4+ T cells. Immunology and Cell Biology. 92(9). 770–780. 15 indexed citations
19.
Abdel‐Mohsen, Mohamed, Matthew C. Strain, Steven M. Lada, et al.. (2014). Decreased HIV Type 1 Transcription in CCR5-Δ32 Heterozygotes During Suppressive Antiretroviral Therapy. The Journal of Infectious Diseases. 210(11). 1838–1843. 10 indexed citations
20.
Yukl, Steven A., Satish K. Pillai, Peilin Li, et al.. (2009). Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 387(1). 98–108. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Salgado Breakdown of academic impact, for papers by Annie David Breakdown of academic impact, for papers by Fabio Romerio Breakdown of academic impact, for papers by Simon Swingler Breakdown of academic impact, for papers by Amy E. Baxter Breakdown of academic impact, for papers by Stanley Kang Breakdown of academic impact, for papers by I S Chen Breakdown of academic impact, for papers by María Rosa López‐Huertas Breakdown of academic impact, for papers by David J. Hooker Breakdown of academic impact, for papers by Matthew Pace
Rankless by CCL
2026